指南与共识泌尿生殖与妇科肿瘤放疗

ESTRO ACROP 共识建议:根治性前列腺切除术后宏观前列腺癌复发的放疗靶区定义

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy.
指南 / 共识 · Clin Transl Radiat Oncol · 2023-09-23

欧洲放射肿瘤学会(ESTRO)放射肿瘤实践咨询委员会(ACROP)前列腺床勾画专家组针对根治性前列腺切除术后放疗(PORT)患者中影像可见的宏观局部复发缺乏标准化方案的问题,成立由12名放射肿瘤学家和1名放射科医师组成的共识小组,通过两个临床场景的勾画和问卷形成共识建议。建议始终勾画整个前列腺床作为临床靶区而非仅勾画局部复发灶,对宏观复发灶的局部加量仅在可见解剖学对应时考虑,其潜在获益应 urgently 在前瞻性临床试验中研究。

要点

  • 建议始终勾画整个前列腺床作为临床靶区,而非仅勾画局部复发灶(原文推荐)。
  • 聚焦「立体定向」方法应保留用于既往PORT后的再照射(原文建议)。
  • 对宏观复发的特定剂量提升仅在可见解剖学对应时考虑,其潜在获益应 urgently 在前瞻性临床试验中研究。

核心结论

  • 建议始终勾画并照射整个前列腺床,而非仅照射局部复发灶,无论复发灶的确切位置如何。
  • 对宏观复发的特定剂量提升仅在可见解剖学对应时考虑,此类局部加量可能可行,前提是优先考虑危及器官(OAR)约束。
  • 可能的剂量还取决于复发灶的位置,其潜在获益应 urgently 在前瞻性临床试验中研究。

研究设计与样本

  • ESTRO ACROP 勾画共识小组由12名放射肿瘤学家和1名放射科医师组成,均具有前列腺癌亚专科专长。
  • 参与者被要求在两个临床相关场景中勾画前列腺床临床靶区(CTV):精囊床局部复发和吻合口水平尖部复发,两者均为前列腺特异性膜抗原(PSMA)阳性且磁共振成像(MRI)上有解剖学对应。
  • 参与者还回答针对靶区勾画详细建议的病例特异性问卷,并通过电子邮件和视频会议进行讨论以最终编辑和达成共识。

主要发现

  • 两个病例的勾画确认了专家组成员之间存在相当大的差异。
  • 最终就共识建议达成一致。
  • 专家组判断可见复发灶外进一步微病灶风险过高,不能安全地将前列腺床其余部分排除在CTV之外。

关键数值与推荐

  • 建议始终勾画整个前列腺床作为临床靶区,而非仅勾画局部复发灶(原文推荐)。
  • 聚焦「立体定向」方法应保留用于既往PORT后的再照射(原文建议)。
  • 对宏观复发的特定剂量提升仅在可见解剖学对应时考虑,此类局部加量可能可行,前提是优先考虑OAR约束,可能的剂量还取决于复发灶的位置。

临床怎么用

  • 对于根治性前列腺切除术后放疗(PORT)患者中影像可见的宏观局部复发,应勾画并照射整个前列腺床,而非仅照射局部复发灶(原文推荐)。
  • 聚焦「立体定向」方法应保留用于既往PORT后的再照射(原文建议)。
  • 对宏观复发的特定剂量提升仅在可见解剖学对应时考虑,并优先考虑OAR约束(原文建议)。
  • 可能的剂量取决于复发灶位置,其潜在获益应 urgently 在前瞻性临床试验中研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Society for Radiotherapy & Oncology (ESTRO) Advisory Committee for Radiation Oncology Practice (ACROP) panel on prostate bed delineation reflected on macroscopic local recurrences in patients referred for postoperative radiotherapy (PORT), a challenging situation without standardized approach, and decided to propose a consensus recommendation on target volume selection and definition. METHODS: An ESTRO ACROP contouring consensus panel consisting of 12 radiation oncologists and one radiologist, all with subspecialty expertise in prostate cancer, was established. Participants were asked to delineate the prostate bed clinical target volumes (CTVs) in two separate clinically relevant scenarios: a local recurrence at the seminal vesicle bed and one apically at the level of the anastomosis. Both recurrences were prostate-specific membrane antigen (PSMA)-avid and had an anatomical correlate on magnetic resonance imaging (MRI). Participants also answered case-specific questionnaires addressing detailed recommendations on target delineation. Discussions via electronic mails and videoconferences for final editing and consensus were performed. RESULTS: Contouring of the two cases confirmed considerable variation among the panelists. Finally, however, a consensus recommendation could be agreed upon. Firstly, it was proposed to always delineate the entire prostate bed as clinical target volume and not the local recurrence alone. The panel judged the risk of further microscopic disease outside of the visible recurrence too high to safely exclude the rest of the prostate bed from the CTV. A focused, "stereotactic" approach should be reserved for re-irradiation after previous PORT. Secondly, the option of a focal boost on the recurrence was discussed. CONCLUSION: Radiation oncologists are increasingly confronted with macroscopic local recurrences visible on imaging in patients referred for postoperative radiotherapy. It was recommended to always delineate and irradiate the entire prostate bed, and not the local recurrence alone, whatever the exact location of that recurrence. Secondly, specific dose-escalation on the macroscopic recurrence should only be considered if an anatomic correlate is visible. Such a focal boost is probably feasible, provided that OAR constraints are prioritized. Possible dose is also dependent on the location of the recurrence. Its potential benefit should urgently be investigated in prospective clinical trials.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Dirix P, Dal Pra A, Khoo V, et al. ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy. Clin Transl Radiat Oncol. 2023. PMID: 37808453. doi:10.1016/j.ctro.2023.100684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。